Year |
Citation |
Score |
2023 |
Jallinoja VIJ, Abbriano CH, Bhatt K, Kaur A, Schlyer DJ, Yazaki PJ, Carney BD, Houghton JL. Pretargeting with Cucurbituril-Adamantane Host-Guest Pair in Xenograft Models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37024305 DOI: 10.2967/jnumed.122.265008 |
0.336 |
|
2020 |
Escorcia FE, Houghton JL, Abdel-Atti D, Pereira PR, Cho A, Gutsche NT, Baidoo KE, Lewis JS. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Theranostics. 10: 151-165. PMID 31903112 DOI: 10.7150/Thno.37098 |
0.332 |
|
2019 |
Huh WJ, Niitsu H, Carney B, McKinley ET, Houghton JL, Coffey RJ. Identification and Characterization of Unique Neutralizing Antibodies to Mouse EGF Receptor. Gastroenterology. PMID 31866246 DOI: 10.1053/J.Gastro.2019.12.017 |
0.325 |
|
2019 |
Huh WJ, Niitsu H, McKinley E, Carney B, Houghton J, Coffey RJ. Sa1741 – Identification and Characterization of the First Neutralizing Antibody to Mouse Egfr Gastroenterology. 156: S-383. DOI: 10.1016/S0016-5085(19)37808-4 |
0.316 |
|
2018 |
Brand C, Sadique A, Houghton JL, Gangangari K, Ponte JF, Lewis JS, Pillarsetty NVK, Konner JA, Reiner T. Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate. Ejnmmi Research. 8: 87. PMID 30155674 DOI: 10.1186/S13550-018-0437-X |
0.605 |
|
2018 |
Escorcia FE, Steckler JM, Abdel-Atti D, Price EW, Carlin SD, Scholz WW, Lewis JS, Houghton JL. Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29508263 DOI: 10.1007/S11307-018-1177-Z |
0.561 |
|
2017 |
Houghton JL, Abdel-Atti D, Scholz WW, Lewis JS. Preloading with unlabeled CA19.9 targeted human monoclonal antibody leads to improved PET imaging with 89Zr‑5B1. Molecular Pharmaceutics. PMID 28191976 DOI: 10.1021/Acs.Molpharmaceut.6B01130 |
0.594 |
|
2017 |
Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry. Molecular Cancer Therapeutics. 16: 124-133. PMID 28062708 DOI: 10.1158/1535-7163.Mct-16-0503 |
0.498 |
|
2017 |
Houghton JL, Lanning R, Abdel-atti D, Jun T, Kearns CM, Schlosser M, Scholz W, Lewis JS, Maffuid PW. Abstract 5204: Preclinical development of MVT-1075 as radioimmunotherapy for pancreatic cancer and other CA19-9 positive malignancies Cancer Research. 77: 5204-5204. DOI: 10.1158/1538-7445.Am2017-5204 |
0.426 |
|
2016 |
Zhang H, Desai P, Koike Y, Houghton J, Carlin SD, Tandon N, Touijer K, Weber WA. Dual modality imaging of prostate cancer with a fluorescent and radiogallium-labeled GRP receptor antagonist. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27516447 DOI: 10.2967/Jnumed.116.176099 |
0.417 |
|
2016 |
Houghton J, Membreno R, Abdel-Atti D, Scholz WW, Zeglis BM, Lewis JS. Abstract 3051: Improving the efficacy of pretargeted radioimmunotherapy in preclinical murine models by utilizing bioorthogonal click chemistry Cancer Research. 76: 3051-3051. DOI: 10.1158/1538-7445.Am2016-3051 |
0.433 |
|
2015 |
Houghton JL, Zeglis BM, Abdel-Atti D, Aggeler R, Sawada R, Agnew BJ, Scholz WW, Lewis JS. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 26668398 DOI: 10.1073/Pnas.1506542112 |
0.599 |
|
2015 |
Meyer JP, Houghton JL, Kozlowski P, Abdel-Atti D, Reiner T, Pillarsetty NV, Scholz WW, Zeglis BM, Lewis JS. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry. Bioconjugate Chemistry. PMID 26479967 DOI: 10.1021/Acs.Bioconjchem.5B00504 |
0.431 |
|
2015 |
Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis JS. Pretargeted immunoPET of pancreatic cancer: overcoming circulating antigen and antibody internalization to reduce radiation doses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26471693 DOI: 10.2967/Jnumed.115.163824 |
0.579 |
|
2015 |
Dimastromatteo J, Houghton JL, Lewis JS, Kelly KA. Challenges of Pancreatic Cancer. Cancer Journal (Sudbury, Mass.). 21: 188-93. PMID 26049698 DOI: 10.1097/Ppo.0000000000000109 |
0.397 |
|
2015 |
Houghton JL, Abdel-Atti DA, Sawada R, Scholz WW, Lewis JS. Abstract B25: Development of 5B1, an anti-CA19.9 monoclonal antibody, as a near-infrared fluorescent probe for intraoperative imaging of pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B25 |
0.53 |
|
2014 |
Zeglis BM, Houghton JL, Evans MJ, Viola-Villegas N, Lewis JS. Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals. Inorganic Chemistry. 53: 1880-99. PMID 24313747 DOI: 10.1021/Ic401607Z |
0.37 |
|
Show low-probability matches. |